Joseph Edelman

Joseph Edelman founded Perceptive Advisors in 1999, building it into one of the most respected healthcare and biotech hedge funds in the United States. Perceptive combines deep scientific analysis of drug pipelines, clinical trial designs, and regulatory pathways with sophisticated financial analysis to make concentrated bets on biotech companies. The fund is known for getting into biotech companies early — often before clinical readouts — and maintaining or exiting positions based on data-driven analysis of scientific outcomes. Edelman has a reputation for conducting unusually thorough scientific due diligence, including consulting with leading researchers and physicians. Perceptive has expanded beyond pure public market investing into a venture arm, participating in biotech company formation and private rounds.